Title: Professor of Law and Director, Public Health Law and Science Center (PHLSC) and Health Law Program
Department: School of Law
Curriculum Vitae: Download in PDF format
Professor Van Tassel clerked for U.S. District Court Judge William K. Thomas before becoming an associate with the international law firm of Squire, Sanders & Dempsey. She began her teaching career in 1997 and currently teaches Health Law: Quality, Cost and Access, Healthcare Organization and Finance, Government Provision of Healthcare, Bioethics, Public Health Law, Food & Drug Law and Torts. She is the Editor of the Health Law Prof Blog, is a regular blogger on Bill of Health, a blog of the Petrie-Flom Center at the Harvard School of Law, and is a regular blogger on Bio Law: Law and the Life Sciences.
She currently serves on the Executive Board of the Law, Medicine and Healthcare Section of the American Association of Law Schools, on the Executive Board of the Law and Mental Disability Section of the American Association of Law Schools and as the Co-Chair of the Food & Drug Law Committee of the Administrative Law Section of the American Bar Association.
Professor Van Tassel’s scholarship has appeared in such journals as the University of Chicago Legal Forum, the Pepperdine Law Review, the Cardozo Law Review, the Connecticut Law Review, the Brooklyn Law Review, the University of Cincinnati Law Review and the Seton Hall Law Review. She is the coauthor of the two-volume treatise Food and Drug Administration (4th ed., forthcoming 2015) which is cited as an authoritative FDA source by the U.S. Supreme Court and numerous circuit and district courts. She is also the co-author on the book Litigating the Nursing Home Case (2nd ed., forthcoming 2014).
Professor Van Tassel is a Hearing Officer for medical staff peer review proceedings and is a consultant for matters involving the abuse and neglect of nursing home residents. She has served as a Special Commissioner on the Cervical Cancer Special Commission of the House of Representatives of the Commonwealth of Massachusetts and as a member of both the Clinical Ethics Review Team and the Institutional Review Board for Experimental Drugs and Devices of the largest hospital system in Western Massachusetts.